April 7, 2016 – Sales Performance International (SPI) is pleased to announce that re-branding of its life sciences practice to SPI Health.
We recognize the unique challenges that pharmaceutical companies face and have a dedicated life sciences practice that is focused on clients in your industry. Our experts understand the financial, political, and demographic environment, and regulatory policies that impact how buying decisions are made for healthcare products, services, and solutions. They work with clients to enable:
- Better Sales Alignment
- Launch Effectiveness
- Mergers and Acquisition Success
With the re-branding, Brad Ansley, Global Director of SPI Health shares, “With so much change happening in the pharmaceutical and medical device industry, it was important for us to create specialized expertise for our clients.”
According to Robert Kear, VP of Innovation Development, “SPI is committed to creating the best solutions for our clients. Brad’s team has done an outstanding job with meeting the evolving needs of life sciences companies.”
For more information on SPI Health, please visit our blog.